Cevimeline Hydrochloride

Product NDC
16571-657
11-digit product format
165710657
Labeler code
16571
Product ID
16571-657_640e50a9-48ba-45e3-a3cb-c14bb313cc4f
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Cevimeline Hydrochloride
Dosage form
CAPSULE
Route
ORAL
Labeler
Rising Pharma Holdings, Inc.
Application
ANDA203775
Marketing category
ANDA
Marketing start
2014-06-17
Substance
CEVIMELINE HYDROCHLORIDE
Active strength
30 mg/1
Pharmacologic classes
Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A203775-001CEVIMELINE HYDROCHLORIDECEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-productTE code
A203775-001AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-09-14 22:38:342026-08A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-0484e616aacf4f…
2026-08-18 06:07:402026-07A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-0431067a03dcf5…
2025-08-23 18:47 UTC2025-08A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-046a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-0403ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-042680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-045bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-0479d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-041e350fbaab3a…
2024-05-31 18:47 UTC2024-05A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-048072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-045c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-045d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-044b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-0474a2ff9319b5…
2022-03-09 01:35 UTC2022-03A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-0487673890dc5c…
2021-03-12 10:30 UTC2021-03A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-045aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-048869cabd3fbd…
2020-11-12 02:37 UTC2020-11A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04c0c555d07b60…
2019-12-14 00:12 UTC2019-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-043f01610625f2…
2019-09-15 20:21 UTC2019-09A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04b00525d2431f…
2019-07-19 19:46 UTC2019-07A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-046a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-041c564ffb4f44…
2023-12-20 04:57 UTC2023-12A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-049b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-043f0d92c62455…
2023-05-13 08:27 UTC2023-05A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04053a50430f4f…
2023-01-26 05:58 UTC2023-01A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-043bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-043a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A203775-001CEVIMELINE HYDROCHLORIDE30MGCAPSULE / ORALAB2014-06-04f41ea6bd6efb…

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 2 · 43 observed states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-09-14 22:38:342026-08A203775-001AB184e616aacf4f…
2026-08-18 06:07:402026-07A203775-001AB1caaa826d4ba7…
2026-02-19 14:30 UTC2026-02A203775-001AB1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A203775-001AB131067a03dcf5…
2025-08-23 18:47 UTC2025-08A203775-001AB16a471c1ec25d…
2025-03-22 03:13 UTC · 3 captures of this ZIP2025-03A203775-001AB1fd3edfee7708…
2025-02-26 10:13 UTC · 3 captures of this ZIP2025-02A203775-001AB1b8a1b40f171c…
2025-01-19 17:59 UTC · 7 captures of this ZIP2025-01A203775-001AB103ed91905a0d…
2024-12-13 21:23 UTC · 2 captures of this ZIP2024-12A203775-001AB12680178bc6a6…
2024-09-14 05:58 UTC · 2 captures of this ZIP2024-09A203775-001AB15bbf6a4d5a75…
2024-11-08 22:44 UTC · 3 captures of this ZIP2024-11A203775-001AB1d8e5a09893c0…
2024-10-29 15:01 UTC2024-10A203775-001AB1d06236e962d9…
2024-08-13 05:28 UTC · 3 captures of this ZIP2024-08A203775-001AB179d66fd596c7…
2024-07-13 05:37 UTC · 2 captures of this ZIP2024-07A203775-001AB1301d65b070ca…
2024-06-18 03:08 UTC · 5 captures of this ZIP2024-06A203775-001AB11e350fbaab3a…
2024-05-31 18:47 UTC2024-05A203775-001AB18072bd15b7f6…
2022-06-29 02:47 UTC · 2 captures of this ZIP2022-06A203775-001AB15c6f7cd8ea54…
2022-04-08 23:34 UTC2022-04A203775-001AB15d02ea3f76ae…
2022-04-04 05:41 UTC2022-04A203775-001AB14b0b4de00fa7…
2019-12-13 00:20 UTC2019-12A203775-001AB174a2ff9319b5…
2022-03-09 01:35 UTC2022-03A203775-001AB1bb7c543d1eb4…
2021-12-28 21:50 UTC2021-12A203775-001AB1782e0a99824c…
2021-05-05 16:15 UTC · 3 captures of this ZIP2021-05A203775-001AB187673890dc5c…
2021-03-12 10:30 UTC2021-03A203775-001AB15aa47cf7b7d7…
2020-12-22 03:56 UTC2020-12A203775-001AB18869cabd3fbd…
2020-11-12 02:37 UTC2020-11A203775-001AB1c0c555d07b60…
2019-12-14 00:12 UTC2019-12A203775-001AB13f01610625f2…
2019-09-15 20:21 UTC2019-09A203775-001AB1b00525d2431f…
2019-07-19 19:46 UTC2019-07A203775-001AB1ea99ee380514…
2024-03-16 18:09 UTC · 4 captures of this ZIP2024-03A203775-001AB16a51e52b5d6a…
2024-02-18 07:12 UTC2024-02A203775-001AB11c564ffb4f44…
2023-12-20 04:57 UTC2023-12A203775-001AB1ea1830bbd6c7…
2023-11-28 05:40 UTC · 2 captures of this ZIP2023-11A203775-001AB1a72a2bbeb626…
2023-10-25 00:34 UTC · 2 captures of this ZIP2023-10A203775-001AB19b2671bbb829…
2023-07-15 15:27 UTC · 2 captures of this ZIP2023-07A203775-001AB1a67488948f0b…
2023-06-13 01:57 UTC · 3 captures of this ZIP2023-06A203775-001AB13f0d92c62455…
2023-05-13 08:27 UTC2023-05A203775-001AB1053a50430f4f…
2023-01-26 05:58 UTC2023-01A203775-001AB13bdfa0b2c4d7…
2022-11-12 20:34 UTC · 5 captures of this ZIP2022-11A203775-001AB13a93d1ddd44b…
2022-10-28 04:53 UTC2022-10A203775-001AB1f41ea6bd6efb…

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

Additional Listing Data#

Finished product
Yes
Brand name base
Cevimeline Hydrochloride
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
CEVIMELINE HYDROCHLORIDE30 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
P81Q6V85NPInternal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
309140Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
IdentifierFDA.report destination
d4bd942a-1339-40c5-8fd4-850da5a69635Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
5ee6cfc6-9666-4038-bf74-eee52d7e4a72Product name420250331

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
16571-657-10Cevimeline Hydrochloride100 in 1 BOTTLECAPSULE1009

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
16571-657-10EA - Each16571-65727a9705e-ca3f-48b2-943d-bfdf4463eea012014-07-02

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
Cevimeline HydrochlorideACTIVE INGREDIENTP81Q6V85NPCEVIMELINE HYDROCHLORIDE CAPSULE [PACK PHARMACEUTICALS, LLC]4
CEVIMELINEACTIVE MOIETYK9V0CDQ56ECEVIMELINE HYDROCHLORIDE CAPSULE [PACK PHARMACEUTICALS, LLC]4
hydroxypropyl celluloseINACTIVE INGREDIENTRFW2ET671PCEVIMELINE HYDROCHLORIDE CAPSULE [PACK PHARMACEUTICALS, LLC]4
lactose monohydrateINACTIVE INGREDIENTEWQ57Q8I5XCEVIMELINE HYDROCHLORIDE CAPSULE [PACK PHARMACEUTICALS, LLC]4
magnesium stearateINACTIVE INGREDIENT70097M6I30CEVIMELINE HYDROCHLORIDE CAPSULE [PACK PHARMACEUTICALS, LLC]4

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
16571-657CEVIMELINE HYDROCHLORIDE CAPSULE [RISING PHARMA HOLDINGS, INC.]9Current NDC, Legacy NDC, 1 package rows20240809_d4bd942a-1339-40c5-8fd4-850da5a69635.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Cevimeline HydrochlorideCEVIMELINE HYDROCHLORIDEASCLEMED USA INC.bcaaec18-4ee1-4cfd-84da-8fe3b8c54fc42026-05-18Warnings, Adverse reactionsExact identifier
application applno (ANDA): 203775
application number: ANDA203775
Cevimeline HydrochlorideCEVIMELINE HYDROCHLORIDEBryant Ranch Prepack51307f82-66f2-41c7-80ff-174d7e50f7ee2024-09-05Warnings, Adverse reactionsExact identifier
application applno (ANDA): 203775
application number: ANDA203775
Cevimeline HydrochlorideCEVIMELINE HYDROCHLORIDERising Pharma Holdings, Inc.d4bd942a-1339-40c5-8fd4-850da5a696352024-08-02Warnings, Adverse reactionsExact identifier
application applno (ANDA): 203775
application number: ANDA203775
ndc (product): 16571-657

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
309140cevimeline HCl 30 MG Oral CapsulePSN51307f82-66f2-41c7-80ff-174d7e50f7ee101
309140cevimeline hydrochloride 30 MG Oral CapsuleSCD51307f82-66f2-41c7-80ff-174d7e50f7ee101
309140cevimeline HCl 30 MG Oral CapsulePSNd4bd942a-1339-40c5-8fd4-850da5a696359
309140cevimeline hydrochloride 30 MG Oral CapsuleSCDd4bd942a-1339-40c5-8fd4-850da5a696359
309140cevimeline HCl 30 MG Oral CapsulePSNbcaaec18-4ee1-4cfd-84da-8fe3b8c54fc41
309140cevimeline hydrochloride 30 MG Oral CapsuleSCDbcaaec18-4ee1-4cfd-84da-8fe3b8c54fc41

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
16571-657-1016571065710100 CAPSULE in 1 BOTTLE (16571-657-10) 100 capsule2014-06-170000-00-00NoNoCurrent